Prevention of Colorectal Cancer Through Multiomics Blood Testing

Completed

Conditions studied: Colon Cancer, Rectal Cancer, Colon Neoplasm, Colon Diseases, Colon Lesion, Colon Polyp, Colorectal Cancer, Polyp, Adenoma, Rectal Diseases, Gastrointestinal Tract Cancers

In brief

The PREEMPT CRC study is a prospective multi-center observational study to validate a blood-based test for the early detection of colorectal cancer by collecting blood samples from average-risk participants who will undergo a routine screening colonoscopy.

Key facts

Study ID
NCT04369053
Run by
Freenome Holdings Inc.
People needed
48995
Starts
2020-05-20
Expected to finish
2024-02-29
Last updated by the study team
2025-12-26

Who can join

Age: 45 and older, up to 85. Sex: any. Healthy volunteers: accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.